Brief: Xeris Names John Shannon As Chair Of The Board
BRIEF-Xeris Names John Shannon As Chair Of The Board June 30 (Reuters) - Xeris Biopharma Holdings Inc XERS.O:
XERIS ANNOUNCES UPDATES TO ITS BOARD OF DIRECTORS
XERIS BIOPHARMA HOLDINGS - APPOINTS JOHN SHANNON AS CHAIR OF THE BOARD
XERIS BIOPHARMA HOLDINGS - MARLA PERSKY TO TRANSITION TO LEAD INDEPENDENT DIRECTOR
Source text: ID:nBw9DHdyxa
Further company coverage: XERS.O
((Reutersbriefs@thomsonreuters.com;))
Recent news on Xeris Biopharma Holdings
See all newsBrief: Xeris Biopharma Files Patent Infringement Lawsuits In US District Court - SEC Filing
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Vor Biopharma, Fair Isaac Corp, Plug Power
Lundbeck expresses interest in buying Xeris, Bloomberg News reports (updated)
Xeris Biopharma rises on report of Lundbeck takeover interest